JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
PNC Financial Services
PNC
$88.2B
| $1.46B | 0.19% |
9,269,208
-1,994,572
| -18% | -$314M |
2013 Q2
38 quarters
|
|
|
AMJ
127
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.46B | 0.19% |
67,135,935
+549,083
| +0.8% | +$12.1M |
2013 Q2
38 quarters
|
|
128
Abbott
ABT
$169B
| $1.43B | 0.19% |
13,045,880
-115,755
| -0.9% | -$12M |
2013 Q2
38 quarters
|
|
129
T-Mobile US
TMUS
$176B
| $1.38B | 0.18% |
9,838,659
+249,772
| +3% | +$35.9M |
2013 Q2
38 quarters
|
|
130
Cigna
CI
$71.5B
| $1.35B | 0.18% |
4,072,730
-252,202
| -6% | -$79.8M |
2013 Q2
38 quarters
|
|
131
Vanguard FTSE Europe ETF
VGK
$29.3B
| $1.34B | 0.18% |
24,164,783
-2,196,231
| -8% | -$116M |
2013 Q2
38 quarters
|
|
132
State Street Financial Select Sector SPDR ETF
XLF
$50.6B
| $1.34B | 0.18% |
39,165,343
+1,716,978
| +5% | +$58.1M |
2013 Q2
38 quarters
|
|
133
Adobe
ADBE
$94.5B
| $1.31B | 0.17% |
3,901,456
+1,477,573
| +61% | +$473M |
2013 Q2
38 quarters
|
|
134
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.03B
| $1.31B | 0.17% |
18,073,920
-563,510
| -3% | -$41.3M |
2020 Q3
9 quarters
|
|
135
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.4B
| $1.3B | 0.17% |
16,820,932
+4,493,698
| +36% | +$345M |
2013 Q2
38 quarters
|
|
136
Uber
UBER
$139B
| $1.28B | 0.17% |
51,796,216
+8,664,672
| +20% | +$237M |
2019 Q2
14 quarters
|
|
|
HZNP
137
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.28B | 0.17% |
11,248,889
+4,461,247
| +66% | +$371M |
2014 Q4
32 quarters
|
|
138
iShares 1-3 Year Treasury Bond ETF
SHY
$26.2B
| $1.24B | 0.16% |
15,255,692
-3,159,357
| -17% | -$256M |
2013 Q2
38 quarters
|
|
139
Infosys
INFY
$44.7B
| $1.23B | 0.16% |
68,061,233
-9,640,541
| -12% | -$179M |
2013 Q2
38 quarters
|
|
140
Vanguard Short-Term Treasury ETF
VGSH
$34.4B
| $1.21B | 0.16% |
21,003,741
-9,960,175
| -32% | -$575M |
2018 Q3
17 quarters
|
|
141
PUT
Tesla
TSLA
$1.46T
| $1.21B | 0.16% |
9,841,600
+1,505,000
| +18% | +$285M |
2014 Q3
33 quarters
|
|
142
DexCom
DXCM
$32.2B
| $1.21B | 0.16% |
10,647,096
+399,056
| +4% | +$43.8M |
2015 Q3
29 quarters
|
|
|
143
Public Service Enterprise Group
PEG
$33.9B
| $1.2B | 0.16% |
19,641,382
+12,488,284
| +175% | +$725M |
2013 Q2
38 quarters
|
|
144
CMS Energy
CMS
$20B
| $1.2B | 0.16% |
18,885,448
+922,417
| +5% | +$54.5M |
2013 Q2
38 quarters
|
|
145
ASML
ASML
$717B
| $1.2B | 0.16% |
2,188,498
+277,396
| +15% | +$145M |
2013 Q2
38 quarters
|
|
146
Sysco
SYY
$37.2B
| $1.19B | 0.16% |
15,564,410
+51,690
| +0.3% | +$4.18M |
2013 Q2
38 quarters
|
|
147
Parker-Hannifin
PH
$123B
| $1.18B | 0.16% |
4,049,849
-331,738
| -8% | -$95M |
2013 Q2
38 quarters
|
|
148
Capital One
COF
$119B
| $1.17B | 0.15% |
12,630,614
-1,050,674
| -8% | -$103M |
2013 Q2
38 quarters
|
|
149
Ventas
VTR
$43.1B
| $1.17B | 0.15% |
25,928,747
+327,656
| +1% | +$13.8M |
2013 Q2
38 quarters
|
|
150
Monster Beverage
MNST
$84.1B
| $1.15B | 0.15% |
45,213,092
+11,906,092
| +36% | +$288M |
2013 Q2
38 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.